Invasive pneumococcal disease in the post vaccine era: Case report

Descripción del Articulo

Invasive pneumococcal disease (IPD) is the most severe clinical presentation of infection by Streptococcus pneumoniae. Peru since 2008 includes pneumococcal vaccine in the national immunization schedule. We report a case of a 10 year old girl who goes by emergency showing meningeal signs; in additio...

Descripción completa

Detalles Bibliográficos
Autores: Miranda Choque, Edwin Albino H., Lázaro Ignacio, Edgar Jony
Formato: artículo
Fecha de Publicación:2016
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/401
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/401
Nivel de acceso:acceso abierto
Materia:Meningitis
Neumococo
Vacuna
Pneumococcal
Vaccine
Descripción
Sumario:Invasive pneumococcal disease (IPD) is the most severe clinical presentation of infection by Streptococcus pneumoniae. Peru since 2008 includes pneumococcal vaccine in the national immunization schedule. We report a case of a 10 year old girl who goes by emergency showing meningeal signs; in addition, abdominal pain, infiltrated right basal hilum on chest radiography, presence of peritoneal fluid and peritoneal adenopathy in diagnostic imaging support. It is isolated in blood and CSF cultures Streptococcus pneumoniae serotype 11A, no vaccine-strain, being sensitive to ceftriaxone and vancomycin. We recommend the need to know more about the presence of not vaccine pneumococcal serotypes in the clinical and epidemiological context and its pathogenic role in Peruvian population.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).